Clinical Trial Update: Iparomlimab and Tuvonralimab Injection Combined With Chemotherapy and Sequential Thoracic Radiotherapy for Extensive-Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of iparomlimab and tuvonralimab with chemotherapy and sequential thoracic radiotherapy for extensive-stage sma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Tuvonralimab (tuvonralimab)
• iparomlimab

Snippet

Sponsor: The Second Affiliated Hospital of Dalian Medical University | Conditions: ES-SCLC | Phase 2 | Status: NOT_YET_RECRUITING